Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies (Q52242595)
Jump to navigation
Jump to search
scientific article published on May 1, 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies |
scientific article published on May 1, 1998 |
Statements
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies (English)
1 reference
A. Berrington
J. Nemunaitis
C. Poole
J. Primrose
A. Rosemurgy
J. Malfetano
P. Brown
A. Cornish
K. Lynch
H. Rasmussen
D. Kerr
D. Cox
1 May 1998
1 reference
4
1 reference
5
1 reference
1101-1109
1 reference